Hemoglobin level as a predictor of major adverse cardiac events during a long-term follow-up in patients with coronary artery disease
Pol Arch Intern Med
.
2022 Dec 21;132(12):16377.
doi: 10.20452/pamw.16377.
Epub 2022 Dec 5.
Authors
Anna Oleksiak
1
,
Cezary Kępka
2
,
Karolina Rucińska
3
,
Kamil Marcinkiewicz
4
,
Marcin Demkow
2
,
Mariusz Kruk
2
Affiliations
1
Department of Intensive Cardiac Therapy, National Institute of Cardiology, Warsaw, Poland. aoleksiak@ikard.pl
2
Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, Warsaw, Poland
3
Department of Cardiac Surgery and Transplantology, National Institute of Cardiology, Warsaw, Poland
4
Department of Intensive Cardiac Therapy, National Institute of Cardiology, Warsaw, Poland
PMID:
36468226
DOI:
10.20452/pamw.16377
No abstract available
MeSH terms
Coronary Artery Bypass
Coronary Artery Disease*
Follow-Up Studies
Hemoglobins
Humans
Substances
Hemoglobins